Achieve Life Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Achieve Life Sciences (ACHV).

Price Target Range — 10 Quarters

Analyst Consensus — 10 Analysts

2S.Buy

8Buy

Consensus RatingBuy# Analysts10Avg. Consensus PT$15Upside to Avg. PT+127.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 30, 2026	Stifel	James Condulis	Initiate	Buy	$18
Aug 13, 2026	Morgan Stanley	Maxwell Skor	Initiate	Overweight	$13
Jun 22, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$12
Apr 21, 2026	Canaccord Genuity	Gary Nachman	Initiate	Buy	$13
Apr 16, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$12
Mar 25, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$12
Nov 25, 2025	Citizens	Jason N. Butler	Initiate	Market Outperform	$19
Aug 21, 2025	HC Wainwright & Co.	Brandon Folkes	Initiate	Buy	$12
Nov 14, 2024	Rodman & Renshaw	Brandon Folkes	Initiate	Buy	$12
Sep 27, 2024	Raymond James	Gary Nachman	Initiate	Strong Buy	$20
Aug 15, 2024	Oppenheimer	Francois Brisebois	Maintained	Outperform	$11
May 13, 2024	Oppenheimer	Francois Brisebois	PT Cut	Outperform	$18→$11
Apr 17, 2024	JonesTrading	Justin Walsh	Initiate	Buy	$20
Apr 1, 2024	Oppenheimer	Francois Brisebois	Maintained	Outperform	$18
Mar 5, 2024	Lake Street	Thomas Flaten	PT Cut	Buy	$19→$11
Dec 12, 2023	Oppenheimer	Francois Brisebois	PT Cut	Outperform	$21→$18

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Stifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18

Stifel analyst James Condulis initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $18.

Benzinga Newsdesk

This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Wall Street analysts changed outlook on top names. Check analyst ratings page for all changes. See what analysts think of MTN stock.

Avi Kapoor

PRO
Morgan Stanley Initiates Coverage On Achieve Life Sciences with Overweight Rating, Announces Price Target of $13

Morgan Stanley analyst Maxwell Skor initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Overweight rating and announces Price Target of $13.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
Canaccord Genuity Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $13

Canaccord Genuity analyst Gary Nachman initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $13.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Buy and maintains $12 price target.

Benzinga Newsdesk

Achieve Life Sciences Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Achieve Life Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Stifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18

This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

PRO
Morgan Stanley Initiates Coverage On Achieve Life Sciences with Overweight Rating, Announces Price Target of $13

PRO
HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

PRO
Canaccord Genuity Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $13

PRO
HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

People Also Watch

People Also Watch

Achieve Life Sciences Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Achieve Life Sciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROStifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18

This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

PROMorgan Stanley Initiates Coverage On Achieve Life Sciences with Overweight Rating, Announces Price Target of $13

PROHC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

PROCanaccord Genuity Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $13

PROHC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

People Also Watch

People Also Watch

PRO
Stifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18

PRO
Morgan Stanley Initiates Coverage On Achieve Life Sciences with Overweight Rating, Announces Price Target of $13

PRO
HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

PRO
Canaccord Genuity Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $13

PRO
HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target